Clover Health held its 2026 Annual Meeting of Stockholders on June 10, 2026. Shareholders elected Demetrios L. Kouzoukas, Andrew Toy, and Thomas L. Tran as Class II directors to serve until 2029. Stockholders approved the non-binding advisory vote on 2025 executive compensation. Ernst & Young LLP was ratified as the independent registered public accounting firm for the 2026 fiscal year.